Circadian rhythm chaos: A new breast cancer marker

被引:0
|
作者
Keith, LG
Oleszczuk, JJ
Laguens, M
机构
[1] Northwestern Univ, Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA
[2] Med Univ Lublin, Dept Obstet & Perinatol, Lublin, Poland
[3] Natl Univ La Plata, Sch Med, Dept Pathol, RA-1900 La Plata, Argentina
关键词
breast cancer; thermography; thermographic imaging; circadian rhythms; public health (cancer); screening; tumor markers;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The most disappointing aspect of breast cancer treatment as a public health issue has been the failure of screening to improve mortality figures. Since treatment of late-stage cancer has indeed advanced, mortality can only be decreased by improving the rate of early diagnosis. From the mid-1950s to the mid-1970s, it was expected that thermography would hold the key to breast cancer detection, as surface temperature increases overlying malignant tumors had been demonstrated by thermographic imaging. Unfortunately, detection of the 1-3 degreesC thermal differences failed to bear out its promise in early identification of cancer. In the intervening two-and-a-half decades, three new factors have emerged: it is now apparent that breast cancer has a lengthy genesis; a long-established tumor-even one of a certain minimum size-induces increased arterial/capillary vascularity in its vicinity; and thermal variations that characterize tissue metabolism are circadian ("about 24 hours") in periodicity. This paper reviews the evidence for a connection between disturbances of circadian rhythms and breast cancer. Furthermore, a scheme is proposed in which circadian rhythm "chaos" is taken as a signal of high risk for breast cancer even in the absence of mammographic evidence of neoplasm or a palpable tumor. Recent studies along this line suggest that an abnormal thermal sign, in the light of our present knowledge of breast cancer, is ten times as important an indication as is family history data.
引用
下载
收藏
页码:238 / 247
页数:10
相关论文
共 50 条
  • [1] The role of circadian rhythm in breast cancer
    Li, Shujing
    Ao, Xiang
    Wu, Huijian
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (04) : 442 - 450
  • [2] The role of circadian rhythm in breast cancer
    Shujing Li
    Xiang Ao
    Huijian Wu
    Chinese Journal of Cancer Research, 2013, 25 (04) : 442 - 450
  • [3] Circadian Rhythm and Concentration of Melatonin in Breast Cancer Patients
    Ahabrach, Hanan
    El Mlili, Nisrin
    Errami, Mohammed
    Cauli, Omar
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (10) : 1869 - 1881
  • [4] Effects of circadian rhythm disorders on breast cancer progression
    Hadadi, Eva
    Acloque, Herve
    M S-MEDECINE SCIENCES, 2021, 37 (05): : 538 - +
  • [5] GENETIC VARIANTS OF GENES IN CIRCADIAN RHYTHM AND RISK OF BREAST CANCER
    Yuan, P.
    Xu, B.
    BREAST, 2013, 22 : S46 - S46
  • [6] Correlation of the risk of breast cancer and disruption of the circadian rhythm (Review)
    Leonardi, Giulia Costanza
    Rapisarda, Venerando
    Marconi, Andrea
    Scalisi, Aurora
    Catalano, Francesca
    Proietti, Lidia
    Travali, Salvo
    Libra, Massimo
    Fenga, Concettina
    ONCOLOGY REPORTS, 2012, 28 (02) : 418 - 428
  • [7] BIOLOGICAL RHYTHM OF DEMENTIA - MEASUREMENT OF MELATONIN AS A MARKER OF CIRCADIAN-RHYTHM
    OKAMOTO, N
    OHARA, K
    UCHIDA, K
    MORITA, Y
    JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1994, 48 (02): : 467 - 468
  • [8] CIRCADIAN-RHYTHM ALTERATION OF SKIN TEMPERATURE IN BREAST-CANCER
    GAUTHERIE, M
    GROS, C
    CHRONOBIOLOGIA, 1977, 4 (01) : 1 - 17
  • [9] Circadian rhythm disrupting behaviours and cancer outcomes in breast cancer survivors: a systematic review
    D'cunha, Kelly
    Park, Yikyung
    Protani, Melinda M.
    Reeves, Marina M.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (03) : 413 - 421
  • [10] Circadian rhythm disrupting behaviours and cancer outcomes in breast cancer survivors: A systematic review
    D'cunha, Kelly
    Park, Yikyung
    Protani, Melinda M.
    Reeves, MarinaM.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 169 - 170